Phibro Animal Health (PAHC) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Phibro Animal Health Corporation Reports Third Quarter Results
May 7, 2020 4:40 PM EDTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its third quarter ended March 31, 2020.
Highlights for the March 2020 quarter (compared to the March 2019 quarter)
Net sales of $211 million, an increase of $5 million, or 2% Net income of $14 million, a decrease of $1 million, or 9% Diluted EPS of $0.33, a decrease of $0.04, or 11% Adjusted EBITDA of $30 million, comparable to the prior year quarter Adjusted diluted EPS of $0.38, a decrease of $0.01, or 3%COMMENTARY
"The... More
